Linezolid (Linospan) 600 mg, 100 tablets: profile, composition and research

Reference page for Linezolid (Linospan) 600 mg, 100 tablets. Active substance: Линезолид / Linezolid.

Key facts

What linezolid is

Linezolid was the first member of the oxazolidinone class to reach clinical practice. The class emerged as a response to bacteria that had become resistant to several antibiotic families at once.

The molecule is fully synthetic: it does not copy a natural antibiotic but has its own structure and its own target inside the bacterial cell. That is why cross-resistance with penicillins, macrolides or fluoroquinolones is usually not seen.

The medicine is taken by mouth. It is absorbed well in the gut, and this allows tablets to be used where intravenous infusions were once required.

How linezolid works

The target

Linezolid binds to the 23S subunit of the bacterial ribosome, the part of the cell protein machinery where the peptide chain is assembled.

What follows

Once attached, it prevents the ribosome from taking the first step of synthesis. Protein is not built, and the bacterium loses the ability to grow and divide.

A note on the mechanism

Unlike many antibiotics, linezolid acts mainly at the initiation stage of translation rather than during its continuation. The effect is described as bacteriostatic: the organism stops multiplying, and the patient's own immune system completes the process.

Approved uses

The manufacturer's information lists bacterial infections of the skin and soft tissues, as well as pneumonia, including cases caused by organisms resistant to other antibiotics.

Infections where the organism is resistant to several agents, such as methicillin-resistant staphylococcus, are mentioned separately. Giving linezolid for a viral infection, including colds and influenza, makes no sense because it does not act on viruses.

The list of indications and the way the medicine is used are decided by a physician after examination, not by a reference page.

Why linezolid is treated as a reserve drug

Linezolid is not a first-line choice for ordinary infections. It is held back for situations where the organism is resistant to simpler options or the patient cannot tolerate them.

That approach lowers the chance that bacteria quickly develop resistance to this molecule as well. Uncontrolled use of antibiotics speeds the process up, so the decision belongs to a physician.

During treatment, blood counts, liver function and neurological status are watched, because changes in these systems have been described with longer courses. The necessary checks are ordered by the doctor.

Published research

Primary sources, verified against PubMed:

• Linezolid: a review of its properties, function, and use in critical care., PubMed 29950810 (Drug design, development and therapy, 2018).
• Linezolid versus vancomycin for skin and soft tissue infections., PubMed 26758498 (The Cochrane database of systematic reviews, 2016).
• Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: The AIDA open label, randomized, controlled Phase 4 trial., PubMed 36618892 (EClinicalMedicine, 2023).

Listed for reference. Publication of a study is not a claim about this particular product.

Precautions

• This is a prescription medicine. Prescribing, dosing and the length of treatment belong to a physician.
• Linezolid does not act on viruses, including those behind colds and influenza. Taking it in a viral infection makes no sense.
• An unfinished course of antibiotics helps resistant bacteria spread.
• Nausea, headache, a metallic taste and changes in stool are possible during treatment. Persistent symptoms should be reported to a doctor.
• Tell your doctor about every other medicine you take: interactions with a number of agents, including some antidepressants, are known.
• Use during pregnancy or breastfeeding is discussed with a doctor individually.

Frequently asked